Matinas Biopharma, Inc
2 clinical trials · Sponsor
◉ Watch Matinas Biopharma, Inc
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL (NCT04662528) | Matinas Biopharma, Inc | 2021-06-01 |
| A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules (NCT02310022) | Matinas Biopharma, Inc | 2014-11-01 |
Track Matinas Biopharma, Inc automatically
Every clearance here is in the API, with alerts when new ones post.